These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3897974

  • 1. [Ceftazidime absorption into bronchial secretions in mucoviscidosis patients].
    Berthelot G, Lenoir G, Grenier B, Tournier G, Sardet A, Steru D, Bergogne-Berezin E.
    Pathol Biol (Paris); 1985 May; 33(5):430-4. PubMed ID: 3897974
    [Abstract] [Full Text] [Related]

  • 2. Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Padoan R, Brienza A, Crossignani RM, Lodi G, Giunta A, Assael BM, Granata F, Passarella E, Vallaperta PA, Xerri L.
    J Pediatr; 1983 Aug; 103(2):320-4. PubMed ID: 6348228
    [Abstract] [Full Text] [Related]

  • 3. Serum and sputum concentrations of azlocillin, cefoperazone and ceftazidime in patients with cystic fibrosis.
    Martini N, Agostini M, Barlocco G, Bozzini L, Castellani L, Messori A, Scroccaro G, Mastella G.
    J Clin Hosp Pharm; 1984 Dec; 9(4):303-9. PubMed ID: 6396321
    [Abstract] [Full Text] [Related]

  • 4. [Bronchial diffusion of new anti-pseudomonal beta-lactams. Clinical significance].
    Bergogne-Berezin E, Pierre J, Berthelot G, Kafe H, Even P, Gibert C, Safran D, Stern M.
    Pathol Biol (Paris); 1984 May; 32(5):421-5. PubMed ID: 6739149
    [Abstract] [Full Text] [Related]

  • 5. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B, Malmborg AS, Alfredson H, Ericsson A.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Penetration of ceftazidime into bronchial secretions in critically ill patients.
    Langer M, Cantoni P, Bellosta C, Boccazzi A.
    J Antimicrob Chemother; 1991 Dec; 28(6):925-32. PubMed ID: 1816189
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas.
    Blumer JL, Stern RC, Klinger JD, Yamashita TS, Meyers CM, Blum A, Reed MD.
    Am J Med; 1985 Aug 09; 79(2A):37-46. PubMed ID: 3895917
    [Abstract] [Full Text] [Related]

  • 12. Response to inhaled ceftazidime in patients with non-cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa.
    Riveiro V, Casal A, Álvarez-Dobaño JM, Lourido T, Suárez-Artime P, Rodríguez-García C, Ferreiro L, Toubes ME, Valdés L.
    Clin Respir J; 2022 Nov 09; 16(11):768-773. PubMed ID: 36017771
    [Abstract] [Full Text] [Related]

  • 13. Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.
    Padoan R, Cambisano W, Costantini D, Crossignani RM, Danza ML, Trezzi G, Giunta A.
    Pediatr Infect Dis J; 1987 Jul 09; 6(7):648-53. PubMed ID: 3302917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical pharmacology of ceftazidime in childhood].
    Sereni F, Rusconi F, Caccamo M, Boccazzi A, Cambisano W, Padoan R.
    G Ital Chemioter; 1984 Jul 09; 31(3):223-7. PubMed ID: 6399037
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.